ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference

Share Article

Kristin Lucas, ClearTrial Senior Director of Clinical Services, will lead a panel of top pharmaceutical financial experts in discussing "Methodologies for Managing Cash Flow and Accruals" at the CBI Forecasting & Budgeting conference. The panel will demonstrate practical ways to gain greater control over clinical trial budgets and improve management of clinical trial cash flow and accruals.

Methodologies for Managing Cash Flow and Accruals

ClearTrial (http://www.cleartrial.com), a leading provider of clinical trial software for clinical trial operations planning, budgeting, and outsourcing, announced today that Kristin Lucas, ClearTrial Senior Director of Clinical Services, will lead a panel of top pharmaceutical financial experts in discussing "Methodologies for Managing Cash Flow and Accruals" at the CBI Forecasting & Budgeting conference. Held at the Crowne Plaza Hotel in Philadelphia, February 3-4, 2009, the conference will bring together senior biopharma executives in clinical operations and finance to share best practices.

With the complexity of clinical trials increasing, managing cash flow and accruals presents significant challenges to clinical operations and financial professionals at biopharma companies. The panel of experts will present proven guidelines for managing accruals in order to effectively manage clinical cash flow, including:

  • Obtaining accurate assessments of accruals based on actual work performed
  • Tracking contract performance and timelines
  • Accurately forecasting and managing one-time start-up fees
  • Effectively managing clinical cash flow

Lucas brings more than 15 years of experience in the pharmaceutical and biotech industry to the conference, with extensive experience in clinical trial budgeting and contract management. Before joining ClearTrial, she led the Financial Administration division for the Clinical Business Management department at ICOS Corporation (an Eli Lilly company), where she worked on the blockbuster drug Cialis®. At ICOS, Lucas was responsible for establishing best practices in the outsourcing, management, drafting and negotiation of site and vendor agreements, as well as the development of a clinical budgeting/modeling application for lifecycle planning, budgeting and in-licensing opportunity assessment. Prior to ICOS, Lucas spent seven years with Genentech, where she was responsible for the negotiation, positioning, and pricing strategy for managed care contracts.

About ClearTrial®
ClearTrial® is a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing. ClearTrial's award-winning software helps pharmaceutical, biotechnology, medical device companies, and CROs expedite the clinical development process without sacrificing quality of results. The company's software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit http://www.cleartrial.com.

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mike Lange
ClearTrial
1-630-986-9800
Email >
Visit website